Predicting the Impact of Mutations in Cancer Using an Integrated Pathway Approach - Sam Ng
Predicting Driver Mutations Across Cancers Using Pathway Logic
Algorithms for Automated Discovery of Mutated Pathways in Cancer - Ben Raphael
Survival Time Prediction from Mutation Profiles Using Gene Networks
Patient-Specific Pathway Analysis Using PARADIGM Identifies Key Activities... - Josh Stuart
Predicting Functional Effect of Human Mutations - Shamil Sunyaev
Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD
Toward Pathway-and Pancancer-Guided Interpretation of an Individual’s Cancer Genome
Pathways of Resistance in Metastatic Colorectal Cancer
Yale Genetics Seminar 9/27/22 | Dr. Ekta Khurana PhD | Cancer evolution...
LRpath Analysis Reveals Common Pathways Dysregulated via DNA Methylation... - Maureen Sartor
Biosimilars and Oncology Clinical Pathways: Perfect Together
Targeting Tumor Mutations for Personalized Cancer Immunotherapy
J. Michael Bishop (UCSF) Part 2: The cancer genome: Challenge and promise
TCGA: Analysis of 3,000 Cancer Exomes to Identify Novel Cancer Drivers - Nickolay Khazanov
Targeting Cancer Pathways: The Epigenetics Question
Integrating the Multi-Ome to Guide Clinical Prediction in Oncology
DriveRank: Discovering Patient-Specific Driver Mutations
ClinAction Workshop: Clinical Implementations of Cancer Susceptibility Genes - Nazneen Rahman
The RNA isoform landscape of cancer
